NRx Pharma's Strategic Partner, Emobot Health, Presents Late-Breaking Poster At 2026 Annual Meeting Of ASCP, Reporting First Pooled Clinical Validation Of EMOCARE
NRX Pharmaceuticals Inc NRXP
$4.42
▼ -0.45%
($-0.02)
Open
$4.43
Prev Close
$4.44
Day Range
$4.29 – $4.59
52W Range
$1.62 – $4.59
Market Cap
$160.13M
Beta
2.18
EPS (TTM)
$-1.28
📋 Company Profile
| Industry | Pharmaceuticals |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2017-11-20 |
| Shares Out. | 36,230,000 |
| Website | nrxpharma.com/ ↗ |
| Phone | 13025750877 |
NRX Pharmaceuticals Inc is a publicly traded company under the ticker symbol NRXP on the NASDAQ NMS - GLOBAL MARKET, operating in the Pharmaceuticals industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
10 analysts (2026-05-01)
📰 Latest News for NRXP
NRx Pharma's HOPE Unit Deploys Zeta Surgical's FDA‑Cleared TMS Navigation System At West Palm Beach Clinic To Deliver Image‑Guided Therapy For Major Depressive Disorder And Other Neurological Conditions
Tuesday's session: top gainers and losers
12 Health Care Stocks Moving In Tuesday's Intraday Session
NRx Pharmaceuticals: 'Sell' On ZYESAMI/NRX-101 Failures & Depression Market Uncertainty
NRx Pharmaceuticals, Inc. (NRXP) Q1 2026 Earnings Call Transcript
Transcript : NRx Pharmaceuticals, Inc., Q1 2026 Earnings Call, May 18, 2026
NRx Pharma Targets FDA Approvals, Expands Clinics And Advances PTSD Drug Pipeline In 2026